Company Profile
Company Profile
Tianjin Puli Ark Medical Technology Co., Ltd. (hereinafter referred to as "Puli Ark") is a wholly-owned subsidiary of Noah Medical Corp. (hereinafter referred to as "Noah") in China. Aiming to usher in a new era of medical robots with next-generation technology, we have launched the new generation of the Galaxy bronchoscope robot for early diagnosis and treatment of patients with corresponding indications.
Development History
Development History
-
- Noah was founded in Silicon Valley, USA.
2018 -
- Puli Ark was established in Tianjin, China.
2021 -
- The FRONTIER clinical trial in Australia has been launched, with the first patient in Australia successfully diagnosed.
2022 -
- The Noah Galaxy system has officially received FDA approval in the United States. The first patient diagnosed in the US and Hong Kong has also been successfully diagnosed.
2023 -
- China Mainland - First patient successfully diagnosed
2024 -
- The Priligy system has officially received NMPA certification in China. The first patient in the US and the first patient in mainland China have been successfully treated. Globally, over 10,000 patients have been successfully diagnosed and treated.
2025 -
- The domestically produced Pulibaichuan disposable robotic bronchoscope has obtained NMPA registration certificate.
2026
-
2018
- Noah was founded in Silicon Valley, USA.
-
2021
- Puli Ark was established in Tianjin, China.
-
2022
- The FRONTIER clinical trial in Australia has been launched, with the first patient in Australia successfully diagnosed.
-
2023
- The Noah Galaxy system has officially received FDA approval in the United States. The first patient diagnosed in the US and Hong Kong has also been successfully diagnosed.
-
2024
- China Mainland - First patient successfully diagnosed
-
2025
- The Priligy system has officially received NMPA certification in China. The first patient in the US and the first patient in mainland China have been successfully treated. Globally, over 10,000 patients have been successfully diagnosed and treated.
-
2026
- The domestically produced Pulibaichuan disposable robotic bronchoscope has obtained NMPA registration certificate.
National unified contact hotline:
022-24892180
Address: 1st Floor, Building 6, Block B, No. 6 Huafeng Road, Huaming High-tech Industrial Zone, Dongli District, Tianjin
Copyright © Tianjin Puli Medical Technology Co., Ltd. All rights reserved.
